DNLI — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.78

Margin Of Safety %

Put/Call OI Ratio

1.7

EPS Next Q Diff

0.05

EPS Last/This Y

0.6

EPS This/Next Y

-0.16

Price

24.82

Target Price

35.44

Analyst Recom

1.15

Performance Q

Upside

-500.3%

Beta

1.01

Ticker: DNLI

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	DNLI	26.49	0.84	0.98	13704
2026-07-14	DNLI	22.65	0.83	0.87	13832
2026-07-15	DNLI	23.02	0.82	10.25	14844
2026-07-16	DNLI	22.73	0.81	16.48	14844
2026-07-17	DNLI	23.3	0.82	0.85	14861
2026-07-20	DNLI	22.9	1.84	1.02	9582
2026-07-21	DNLI	23.84	1.80	0.26	10022
2026-07-22	DNLI	23.65	1.82	6.30	10031
2026-07-23	DNLI	23.42	1.82	0.31	10042
2026-07-24	DNLI	23.11	1.85	0.65	10032
2026-07-27	DNLI	23.58	1.86	1.00	10024
2026-07-28	DNLI	24.04	1.79	0.00	10580
2026-07-29	DNLI	23.84	1.76	0.02	10655
2026-07-30	DNLI	24.33	1.77	0.00	10618
2026-07-31	DNLI	23.01	1.77	3.13	10626
2026-08-03	DNLI	23.16	1.79	0.50	10746
2026-08-04	DNLI	24.18	1.78	29.50	10751
2026-08-05	DNLI	24.48	1.78	0.03	10752
2026-08-06	DNLI	24.74	1.76	0.00	10806
2026-08-07	DNLI	24.81	1.70	0.91	10940
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	DNLI	26.49	26.0	-	-2.32
2026-07-14	DNLI	22.68	26.0	-	-2.32
2026-07-15	DNLI	23.02	24.3	-	-2.35
2026-07-16	DNLI	22.73	24.3	-	-2.35
2026-07-17	DNLI	23.28	24.3	-	-2.35
2026-07-20	DNLI	22.88	24.3	-	-2.35
2026-07-21	DNLI	23.83	24.3	-	-2.35
2026-07-22	DNLI	23.66	35.1	-	-2.33
2026-07-23	DNLI	23.43	35.1	-	-2.33
2026-07-24	DNLI	23.10	35.1	-	-2.37
2026-07-27	DNLI	23.57	35.1	-	-2.37
2026-07-28	DNLI	24.02	35.1	-	-2.37
2026-07-29	DNLI	23.84	35.1	-	-2.37
2026-07-30	DNLI	24.38	35.1	-	-2.37
2026-07-31	DNLI	23.00	35.1	-	-2.37
2026-08-03	DNLI	23.16	35.1	-	-2.37
2026-08-04	DNLI	23.16	35.1	-	-2.37
2026-08-05	DNLI	24.43	35.1	-	-2.37
2026-08-06	DNLI	24.79	35.1	-	-2.37
2026-08-07	DNLI	24.82	35.1	-	-2.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	DNLI	0.00	3.71	10.72
2026-07-14	DNLI	0.00	3.71	10.72
2026-07-15	DNLI	0.00	3.71	10.72
2026-07-16	DNLI	0.00	3.71	10.72
2026-07-17	DNLI	0.00	3.71	10.72
2026-07-20	DNLI	0.00	3.77	10.72
2026-07-21	DNLI	0.00	3.77	10.72
2026-07-22	DNLI	0.00	3.77	10.72
2026-07-23	DNLI	0.00	3.77	10.72
2026-07-24	DNLI	0.00	3.77	10.72
2026-07-27	DNLI	0.00	3.60	10.78
2026-07-28	DNLI	0.00	3.60	10.78
2026-07-29	DNLI	0.00	3.60	10.78
2026-07-30	DNLI	0.00	3.60	10.78
2026-07-31	DNLI	0.00	3.60	10.78
2026-08-03	DNLI	0.00	2.92	10.78
2026-08-04	DNLI	0.00	2.92	10.78
2026-08-06	DNLI	0.00	2.92	10.78
2026-08-07	DNLI	0.00	2.92	10.78
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.69

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.64

Insider Transactions

Institutional Transactions

2.92

Beta

1.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

56.3

Max Drawdown 5-Year %

-79.5

Target Price

35.44

P/E

Forward P/E

PEG

P/S

1094.66

P/B

4.75

P/Free Cash Flow

EPS

-2.84

Average EPS Est. Cur. Y

-2.37

EPS Next Y. (Est.)

-2.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14191.2

Relative Volume

0.95

Return on Equity vs Sector %

-82.2

Return on Equity vs Industry %

-66.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.06

EBIT Estimation

◆ DNLI Healthcare

$24.83

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

12/25

Volume

7/15

Valuation

9/20

TP/AR

2/10

Options

3/10

RSI

56.7

Range 1M

46.9%

Sup Dist

1.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

11/30

Estimates

0/20

Inst/Vol

5/15

Options

1/10

EPS Yr

24%

52W%

80.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +42.7% upside

Quality

2/30

Valuation

11/30

Growth

8/25

Stability

9/10

LT Trend

2/5

Upside

+42.7%

Quality

DNLI — P/E HistoricalBiotechnology

Denali Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 503

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

DNLI

Latest News

—

Caricamento notizie per DNLI…

stock quote shares DNLI – Denali Therapeutics Inc. Stock Price stock today

news today DNLI – Denali Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DNLI – Denali Therapeutics Inc. yahoo finance google finance

stock history DNLI – Denali Therapeutics Inc. invest stock market

stock prices DNLI premarket after hours

ticker DNLI fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DNLI

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y